Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 1467 entries
View as:

SAR3419 as Single Agent in Relapsed-Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients

Phase: N/A Priority: Normal
NCT ID: NCT01472887 Org: User:
Start: 01/31/12 End: 09/30/16 Due: 09/30/17

Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta

Phase: N/A Priority: Normal
NCT ID: NCT01252355 Org: User:
Start: 01/31/11 End: 04/30/13 Due: 04/30/14

Postprandial Glucodynamic Response to Insulin Glargine/Lixisenatide Fixed Ratio Combination in Japanese Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02713477 Org: User:
Start: 04/30/16 End: 06/30/16 Due: 06/30/17

Safety and Efficacy Study of ChimeriVax™-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending Age

Phase: N/A Priority: Normal
NCT ID: NCT00441259 Org: User:
Start: 01/31/07 End: 12/31/11 Due: 12/31/12

A Study to Compare Pharmacokinetics and Pharmacodynamics of SAR342434 to Insulin Lispro in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02273258 Org: User:
Start: 03/31/13 End: 07/31/13 Due: 07/31/14

Insulin Glargine Combination Therapies in Type II Diabetics

Phase: N/A Priority: Normal
NCT ID: NCT00783744 Org: User:
Start: 12/31/01 End: - Due: -

A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polyps

Phase: N/A Priority: Normal
NCT ID: NCT06691113 Org: User:
Start: 12/16/24 End: 02/09/27 Due: 02/09/28

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.

Phase: N/A Priority: Normal
NCT ID: NCT06637631 Org: User:
Start: 12/10/24 End: 05/23/29 Due: 05/23/30

A Study to Investigate the Efficacy and Safety of Subcutaneous Lunsekimig (SAR443765) Compared With Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT06790121 Org: User:
Start: 02/03/25 End: 07/15/26 Due: 07/15/27

Effect of Alirocumab (SAR236553/REGN727) Administered on Top of Ezetimibe or Fenofibrate on Lipid Profiles in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01723735 Org: User:
Start: 11/30/12 End: 07/31/13 Due: 07/31/14

Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®)

Phase: N/A Priority: Normal
NCT ID: NCT00982137 Org: User:
Start: 07/31/04 End: 03/31/07 Due: 03/31/08

Efficacy, Safety, and Tolerability of Ambien (Zolpidem) in the Treatment of Children Ages 6 to 17 With Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT00318448 Org: User:
Start: 04/30/06 End: 08/31/06 Due: 08/31/07

Insulin Glulisine Administered Pre-meal Versus Post-meal in Adult Subjects With Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal Insulin

Phase: N/A Priority: Normal
NCT ID: NCT00135096 Org: User:
Start: 08/31/04 End: 07/31/07 Due: 07/31/08

Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Study

Phase: N/A Priority: Normal
NCT ID: NCT06914908 Org: User:
Start: 05/12/25 End: 01/29/31 Due: 01/29/32

Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children

Phase: N/A Priority: Normal
NCT ID: NCT00391391 Org: User:
Start: 10/31/06 End: 10/31/07 Due: 10/31/08

Health Assessment, Patient Treatment Satisfaction and Quality-of-Life in Insulin-Naive Type 2 Diabetes Patients

Phase: N/A Priority: Normal
NCT ID: NCT00941369 Org: User:
Start: 06/30/09 End: 10/31/12 Due: 10/31/13

Efficacy and Safety Assessment of ZOlpidem (Stilnox CR) in Patients With Chronic insomNIA

Phase: N/A Priority: Normal
NCT ID: NCT01024192 Org: User:
Start: 11/30/09 End: 07/31/10 Due: 07/31/11

Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02842359 Org: User:
Start: 08/23/16 End: 04/19/18 Due: 04/19/19

Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04478266 Org: User:
Start: 10/14/20 End: 05/26/23 Due: 05/26/24

Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) in Patients With Primary Hypercholesterolemia on Stable Atorvastatin Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01288443 Org: User:
Start: 01/31/11 End: 12/31/11 Due: 12/31/12

Sotagliflozin Multiple-dose Study in Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03909451 Org: User:
Start: 04/28/19 End: 08/19/19 Due: 08/19/20

Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on Teriflunomide

Phase: N/A Priority: Normal
NCT ID: NCT01403376 Org: User:
Start: 09/30/11 End: 01/31/12 Due: 01/31/13

Safety Study of XL765 (SAR245409) in Combination With Erlotinib in Adults With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00777699 Org: User:
Start: 08/31/08 End: 02/28/11 Due: 02/28/12

Single Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluation of Eplivanserin in Children With Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT00913614 Org: User:
Start: 06/30/09 End: 12/31/09 Due: 12/31/10

Safety Study of Sargramostim in Treating Patients With Mild Cognitive Impairment Due to Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02667496 Org: User:
Start: 11/30/16 End: 03/31/17 Due: 03/31/18